Balanitis News and Research

RSS
Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

EU approves Forxiga for treatment of type 2 diabetes

EU approves Forxiga for treatment of type 2 diabetes

Antifungal resistance of Candida genital isolates on the increase

Antifungal resistance of Candida genital isolates on the increase

Antifungal resistance of Candida genital isolates on the increase

Antifungal resistance of Candida genital isolates on the increase

Effective ways to reduce risk of vaginal yeast infection

Effective ways to reduce risk of vaginal yeast infection

Long-term clinical follow up of children with primary vesicoureteric reflux

Long-term clinical follow up of children with primary vesicoureteric reflux